Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Analyst lays out 'doomsday scenario' for federal probe of AstraZeneca's Brilinta
Fierce Biotech
Tuesday, November 5, 2013 - 11:21am
tags:
AstraZeneca, Brilinta
Novartis chopping 371 research jobs in global R&D shakeup
Fierce Biotech
Tuesday, November 5, 2013 - 11:12am
tags:
Novartis, R&D, layoffs
Watch Out: Barbarians At The Gate For Oxygen Biotherapeutics
TheStreet.com
Tuesday, November 5, 2013 - 11:11am
tags:
Oxygen Biotherapeutics
Loss Expected to Widen for Arena Pharmaceuticals
Forbes
Tuesday, November 5, 2013 - 11:10am
tags:
Arena Pharmaceuticals, earnings
Immunogen's 'Smart Bomb' Cancer Drugs Are Flunking Safety Checks
TheStreet.com
Tuesday, November 5, 2013 - 10:15am
tags:
Immunogen, IMGN901
This Diabetes Giant Could Face 3 Major Challenges
Motley Fool
Tuesday, November 5, 2013 - 9:57am
tags:
diabetes, Novo Nordisk, Tresiba, GLP-1 agonist, Victoza
Keryx's kidney drug meets main goals of mid-stage study
Yahoo/Reuters
Tuesday, November 5, 2013 - 9:56am
tags:
Keryx, Zerenex, chronic kidney disease
Regeneron earnings beat forecasts, Eylea outlook higher
Yahoo/Reuters
Tuesday, November 5, 2013 - 9:35am
tags:
earnings, Regeneron
Does Reckitt's drug business make a match with Shire?
Fierce Pharma
Tuesday, November 5, 2013 - 9:24am
tags:
Shire, Reckitt Benckiser, M&A
We Like What We're Seeing In Big Pharma
Seeking Alpha
Tuesday, November 5, 2013 - 8:42am
tags:
Bristol-Myers Squibb, AbbVie, Eli Lilly
Gabapentin Gets A Boost In Treating Alcoholism
Forbes
Tuesday, November 5, 2013 - 8:41am
tags:
gabapentin, alcoholism, generics, Pfizer
Drug pricing challenges diabetes king Novo Nordisk
Reuters
Tuesday, November 5, 2013 - 8:38am
tags:
drug pricing, diabetes, Novo Nordisk
Shire's ADHD drug succeeds in trial to treat binge eating
Reuters
Tuesday, November 5, 2013 - 8:37am
tags:
Shire, binge eating, ADHD, Vyvanse
Novartis Said to Mull Animal-Health Sale in Asset Review
Bloomberg
Tuesday, November 5, 2013 - 8:20am
tags:
Novartis, animal health
Will GlaxoSmithKline Get Away in China?
Wall St. Cheat Sheet
Tuesday, November 5, 2013 - 8:12am
tags:
China, GSK
Endo Health buying Paladin Labs for about $1.5B
Yahoo/AP
Tuesday, November 5, 2013 - 8:11am
tags:
Paladin, Endo Health Solutions, M&A
Veracyte, Inc. Announces Closing of Initial Public Offering
Yahoo
Tuesday, November 5, 2013 - 8:09am
tags:
Veracyte, IPOs
Meet the Tiny Biotech Challenging Amgen and General Electric
Motley Fool
Tuesday, November 5, 2013 - 8:08am
tags:
Amgen, Repligen, General Electric
Therapeutic vaccine upstart Hookipa snags $27M round to fund PhI move
Fierce Biotech
Monday, November 4, 2013 - 4:46pm
tags:
Hookipa, vaccines
Ex-Lilly contract sales rep sues, claiming unpaid bonuses
Fierce Pharma
Monday, November 4, 2013 - 4:39pm
tags:
Eli Lilly, contract reps

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.